Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Core Viewpoint - Sonoma Pharmaceuticals, Inc. is participating in the Lytham Partners Fall 2025 Investor Conference, indicating its ongoing engagement with investors and the market [1] Company Participation - The company will host a webcast presentation on September 30, 2025, at 2:00 p.m., showcasing its patented Microcyn® technology and its applications [1] - Sonoma Pharmaceuticals will also conduct one-on-one meetings with investors during the conference, highlighting its commitment to investor relations [1] Product Focus - The company specializes in developing and producing stabilized hypochlorous acid (HOCl) products for various applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care [1]